Mycophenolate mofetil for the treatment of takayasu arteritis: Report of three cases

Annals of Internal Medicine

Volumn 130, Issue 5, 1999, Pages 422-426

  Daina, Erica ^a,b   Schieppati, Arrigo ^a,b   Remuzzi, Giuseppe ^a,b  

^a OSPEDALI RIUNITI   (Italy)

^b MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GLUCOCORTICOID; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; AORTA ARCH SYNDROME; ARTICLE; CASE REPORT; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME; WORK RESUMPTION;

EID: 0033515011     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-130-5-199903020-00013     Document Type: Article

References (15)

1. Judge RD, Currier RD, Gracie WA, Figley MM. Takayasu's arteritis and the aortic arch syndrome. Am J Med. 1962;32:379-92.
2. Conference on Comparative Studies of Takayasu Arteritis among Asian Countries. Tokyo, Japan, May 16-17, 1991. Heart Vessels Suppl. 1992;7:1-178.
3. Lupi-Herrera E, Sanchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Vela JE. Takayasu's arteritis. Clinical study of 107 cases. Am Heart J. 1977;93:94-103.
4. Hotchi M. Pathological studies on Takayasu arteritis. Heart Vessels Suppl. 1992;37:11-7.
5. Hoffman GS, Leavitt RY, Kerr GS, Rottem M, Sneller MC, Fauci AS. Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum. 1994;37:578-82.
6. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, et al. Takayasu arteritis. Ann Intern Med. 1994;120:919-29.
7. Mathew TH. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation. 1998;65:1450-4.
8. Talar-Williams C, Hijazi YM, Walther MM, Linehan MW, Hallahan CW, Lubensky I, et al. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis. Ann Intern Med. 1996;124:477-84.
9. Guttierez-Urena S. Molina JF, Garcia CO, Cuellar ML, Espinoza LR. Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis. Arthritis Rheum. 1996;39:272-6.
10. Allison AC, Eugui EM. Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil. Immunol Rev. 1993; 135:5-28.
11. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group Lancet. 1995;345:1321-5.
12. Sollinger HW. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation 1995;60:225-32.
13. McManus RP, O'Hair DP, Hunter JB, Komorowski R. Spectrum of vascular pathologic changes in primate cardiac xenografts. Transplant Proc. 1992; 24:619-24.
14. Foegh ML. Chronic rejection - graft arteriosclerosis. Transplant Proc. 1990; 22:119-22.
15. Briggs WA, Choi MJ, Scheel PJ Jr. Successful mycophenolate mofetil treatment of glomerular disease. Am J Kidney Dis. 1998;31:213-7.